Leng Fucheng, Shemchuk Oleksii, Robeyns Koen, Leyssens Tom
Institute of Condensed Matter and Nanosciences, Université Catholique de Louvain, 1 Place Louis Pasteur, B-1348 Louvain-La-Neuve, Belgium.
Pharmaceutics. 2022 Sep 16;14(9):1960. doi: 10.3390/pharmaceutics14091960.
Combining different drugs into a single crystal form is one of the current challenges in crystal engineering, with the number of reported multi-drug solid forms remaining limited. This paper builds upon an efficient approach to combining Active Pharmaceutical Ingredients (APIs) containing carboxylic groups in their structure with APIs containing pyridine moieties. By transforming the former into their zinc salts, they can be successfully combined with the pyridine-containing APIs. This work highlights the successfulness of this approach, as well as the improvement in the physical properties of the obtained solid forms.
将不同药物组合成单一晶体形式是晶体工程当前面临的挑战之一,已报道的多药物固体形式数量仍然有限。本文基于一种有效的方法,该方法将结构中含有羧基的活性药物成分(API)与含有吡啶部分的API相结合。通过将前者转化为它们的锌盐,可以成功地与含吡啶的API组合。这项工作突出了这种方法的成功之处,以及所得固体形式物理性质的改善。